Dublin, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/vx...ll_culture ) has announced the addition of the "3D Cell Culture Market, 2015 - 2025" report to their offering. The 3D Cell Culture Market, 2015-2025' report provides an extensive study on the marketed 3D cell culture systems and those under development. There are a number of 3D cell culture systems that are already commercially available. However, these systems are primarily being used in a variety of research applications; therapeutic applications are still being explored. In addition, there are several promising 3D culture systems which are currently being developed worldwide; the approach is likely to result in many commercial success stories in the foreseen future. The report covers various aspects, such as, key players in the industry, 3D culture products in various biomedical applications and upcoming opportunities for several stakeholders. As pharmaceutical companies continue to expand their research programs in this area, one of the key objectives outlined for this report is to understand the current and future potential of the market. This is done by analysing current trends in the wider cell culture market and the specific parameters which are likely to influence evolution of 3D cultures during the same time period. In addition, we have provided our outlook on the sub-market evolution of 3D culture instruments, 3D culture related consumables, 3D culture services and other biomaterials. We have also reviewed, in detail, the likely contribution to be made by different applications areas such as cancer research, drug and toxicity screening, stem cell research and regenerative medicines. The report also provides a snapshot of the likely evolution of the market across key geographies (US, EU and Asia). To address the uncertainties in the market, we have provided three market forecast scenarios for the time period 2015 - 2025. The conservative, base and optimistic scenarios represent three different tracks of industry evolution. Our opinions and insights, presented in this study, were influenced by the discussions that we conducted with experts in this area. All actual figures have been sourced and analysed from publicly available information and discussions with industry experts. The figures mentioned in this report are in USD, unless otherwise specified. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Classification of 3D Culture Methods 5. 3D Matrix Fabrication 6. 3D Culture Market Landscape 7. 3D Culture in Cancer Research 8. 3D Culture in Drug and Toxicity Screening 9. 3D Culture Applications in Stem Cell Research 10. Market Size and Forecast 11. Company Profiles
Companies Featured
- 3D Biomatrix - 3D Biotek, LLC - 4titude - Abbvie - Agilent - Akron Biotechnology, LLC - Alphagenix - AMS Bio - AstraZeneca Pharmaceuticals - Austrianova - Avanticell Science - BASF - BD Bioscience - BellBrook Labs - Bethesda Research Laboratories - Bio Connect - Bio-Byblos Biomedical Co. Ltd. - BioCellChallenge - Biogelx Ltd. - Biomerix - Biozol GmbH - BRTI Life Sciences - Celartia - Celenys SAS - CellecBiotek AG - Cellendes GmbH - ChemieBrunschwig AG - Cleveland Clinic - Clontech - CN Bio Innovations Ltd. - Corning Life Sciences - Cosmo Bio Co. Ltd. - Cytoo - Dexter Corporation - Durham University - EMD Millipore - Emulate Inc. - ESI Bio - Euroclone - European Union's Seventh Framework Programme (FP7) for Research and Technology Development - Factors Technical University Dortmund - FMC BioPolymer AS - Fujifilm - GE Healthcare - GeneON GmbH - Generon - GIBCO Corporation - GlaxoSmithKline - Global Cell Solutions - GlycosanBioSystems - Greiner Bio-one - Hµrel Corporation - Hamilton Company - Heidelberg University Hospital - Hepregen Corp - Hokkaido Soda - In Vitro AS - Insphero - Instron - Invivo Sciences - Iris Biosciences - Japan Vilene Company - Karolinska Institute - Kirkstall - Kiyatec - Koken Co. Ltd. - Kolloidis Biosciences - Kuraray Co., Ltd. - Leibniz Research Centre For Working Environment and Human - Lena Biosciences - Life Technologies - Lifecore Biomedical, - Locate Therapeutics - LuoLabs - Massachusetts General Hospital - MatTek Corporation - MC2 Biotek - Mebiol Inc. - Medicyte - Menicon Life Science - Merck - MicroTissues Inc. - Mimetas B.V. - Mirus Bio - n3D Biosciences, Inc. - Nanofiber Solutions - NASA - National Cancer Institute - National Institute of Health - National Institute of Standards and Technology - NC3Rs - Neuromics - NOF Corporation - Oncotest GmbH - Organovo Holdings Inc. - ParticipatiemaatschapijOost Nederland - PepGel LLC - Pfizer - Prodizen - Promega - Protea Biosciences - Protista International AB - QGel Bio - Radboudumc Pharmacology - RealBio Technology Inc. - Reinnervate - Roche - RoslinCellab - Sanofi - SBH Sciences - Scivax Life Sciences - Sigma Aldrich - Solidus Biosciences, Inc. - SoloHill - Stemcell Technologies - Sumitomo Bakelite Co. Ltd. - Swiss Federal Institute of Technology - Swiss FHNW - Synthecon Incorporated - SynVivo LLC - TAP Biosystems - Tecan - Thermo Scientific - Tianjin WeikaiBioeng Ltd. - Trevigen - Univalor - University College London - University of Illinois - University of Liverpool - University of Reading - University of Utrecht - University Zurich - UPM - VesselxIKKO-ZU - VistaGen Therapeutics - Vivo Biosciences - WiCell Research Institute - Wyss Institute, Harvard University - ZeeuwsInvesteringsFonds - Zyoxel For more information visit http://www.researchandmarkets.com/research/vx...ll_culture
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology
